[1]王丹,朱吕群,徐春阳,等.穴位揿针结合补阳还五汤化裁方改善肝癌TACE术后疼痛临床观察[J].陕西中医,2025,46(12):1702-1706.[doi:DOI:10.3969/j.issn.1000-7369.2025.12.024]
　WANG Dan,ZHU Lvqun,XU Chunyang,et al.Observation on clinical effect of acupoint press-needle combined with modified Buyang Huanwu decoction on improving pain after TACE for liver cancer[J].,2025,46(12):1702-1706.[doi:DOI:10.3969/j.issn.1000-7369.2025.12.024]
点击复制

穴位揿针结合补阳还五汤化裁方改善肝癌TACE术后疼痛临床观察

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
46
期数:
2025年12期
页码:
1702-1706
栏目:
针灸经络
出版日期:
2025-12-05

文章信息/Info

Title:
Observation on clinical effect of acupoint press-needle combined with modified Buyang Huanwu decoction on improving pain after TACE for liver cancer
作者:
王丹; 朱吕群; 徐春阳; 沈建军
（南京中医药大学附属南京医院 南京市第二医院中医科，江苏 南京 210003)
Author(s):
WANG Dan; ZHU Lvqun; XU Chunyang; SHEN Jianjun
（Department of Traditional Chinese Medicine,Nanjing Hospital， Nanjing Second Hospital,Nanjing University of Traditional Chinese Medicine,Nanjing 210003,China）
关键词:
肝癌TACE术; 疼痛; 穴位揿针; 补阳还五汤化裁方; 气虚血瘀证; 中医证候积分
Keywords:
TACE for liver cancer; Pain; Acupoint press-needle; Modified Buyang Huanwu decoction; Qi deficiency and blood stasis syndrome; TCM syndromes scores
分类号:
R 735.7
DOI:
DOI:10.3969/j.issn.1000-7369.2025.12.024
文献标志码:
A
摘要:
目的：探索穴位揿针结合补阳还五汤化裁方改善原发性肝癌患者经导管动脉化疗栓塞术(TACE)后疼痛的临床效果。方法：选取行TACE的130例原发性肝癌术后疼痛(气虚血瘀证)患者作为研究对象，通过随机数字法随机分为观察组和对照组各65例。对照组患者予以常规西医止痛药物，观察组在对照组基础上进行穴位揿针结合补阳还五汤化裁方进行治疗。比较两组患者治疗前及治疗4周后的疼痛状态[视觉模拟评分(VAS)]、疼痛通路相关因子[β-内啡肽、P物质、5-羟色胺(5-HT)]、中医证候积分、血流动力学指标[搏动指数(PI)、阻力指数(RI)、收缩期峰值流速(PSV)]、血清炎症因子[肿瘤坏死因子-α(TNF-α)、白细胞介素-1β(IL-1β)、白细胞介素-6(IL-6)]、生活质量[欧洲癌症研究与治疗组织生活质量核心量表(EORTC QLQ-C30)]。比较两组患者在治疗期间的不良反应发生状况(肝、肾功能异常、凝血功能异常、皮肤过敏、胃肠道不适等)。结果：治疗4周后，两组患者VAS评分、中医证候积分、部分血流动力学指标(PI、RI)、血清炎症因子、部分疼痛通路相关因子(P物质、5-HT)水平及EORTC QLQ-C30(疼痛症状)评分均较治疗前显著降低，且观察组低于同期对照组(P＜0.05)，而β-内啡肽、PSV水平及EORTC QLQ-C30(整体健康状况、躯体功能)评分则较治疗前显著升高，且观察组高于同期对照组(P＜0.05)；两组患者治疗期间不良反应发生率比较无统计学差异(P＞0.05)。结论：穴位揿针结合补阳还五汤化裁方改善肝癌TACE术后疼痛的临床效果理想，患者疼痛症状、炎症反应及血流动力学状态改善显著。
Abstract:
Objective:To explore the clinical effect of acupoint press-needle combined with modified Buyang Huanwu decoction on improving pain in patients with primary liver cancer after transcatheter arterial chemoembolization (TACE).Methods:130 cases with postoperative pain of primary liver cancer (qi deficiency and blood stasis syndrome) who received TACE were selected as research subjects,and were randomly divided into observation group and control group by random number table method,with 65 cases in each group.The patients in the control group were treated with conventional western medicine analgesic drugs,while the patients in the observation group were given acupoint press-needle combined with modified Buyang Huanwu decoction on the basis of the control group.The pain status [visual analogue scale (VAS)],pain pathway related factors [β-endorphin,substance P,5-hydroxytryptamine (5-HT)],TCM syndromes scores,hemodynamic indexes [pulsatility index (PI),resistance index (RI),peak systolic velocity (PSV)],serum inflammatory factors [tumor necrosis factor-α (TNF-α),interleukin-1β (IL-1β),interleukin-6 (IL-6)] and quality of life [European Organization for Research and Treatment of Cancer Quality of Life Core Scale (EORTC QLQ-C30)] before treatment and after 4 weeks of treatment and occurrence status of adverse reactions (abnormal liver-kidney function,abnormal coagulation function,skin allergy,gastrointestinal discomfort,etc.) during treatment were compared between the two groups of patients.Results:After 4 weeks of treatment,the VAS score,TCM syndromes scores,parital hemodynamic indexes (PI,RI),serum inflammatory factors,partial pain pathway related factors (substance P,5-HT) and EORTC QLQ-C30 score (pain symptom) in the two groups of patients were significantly reduced compared with those before treatment,and the above indexes in observation group were lower than those in control group (P<0.05),and the β-endorphin,PSV and EORTC QLQ-C30 scores (overall health status,physical function) were significantly enhanced compared to before treatment,and the indexes were higher in observation group than those in control group (P<0.05).No statistical differences were observed in the incidence rates of adverse reactions between the two groups during treatment (P>0.05).Conclusion:Acupoint press-needle combined with modified Buyang Huanwu decoction has an ideal clinical effect on improving pain after TACE for liver cancer,and can significantly improve the pain symptoms,inflammatory response and hemodynamic status.

参考文献/References:

[1]赖全友,高远,王尚毓,等.MRI联合血清赖氨酸氧化酶样蛋白4、信号转导和转录激活因子3检测用于原发性肝癌诊断的价值[J].陕西医学杂志,2024,53(10):1398-1401，1406.
[2]李俊漪,徐剑.龙胆泻肝汤对原发性肝癌肝动脉栓塞化疗术后患者肝功能及肿瘤标志物的影响研究[J].陕西中医,2024,45(10):1353-1356.
[3]吉银,戴铭,王振常,等.逍遥散合大黄虫丸治疗原发性肝癌经肝动脉化疗栓塞术后气滞血瘀型疗效研究[J].陕西中医,2024,45(2):187-190.
[4]许文君,李晶滢,汪晓军,等.槲芪癥消方对TACE治疗后Ⅲ期乙型肝炎相关性原发性肝癌正气不足、毒瘀内结证患者生存率及生活质量的影响[J].中医杂志,2024,65(4):382-387.
[5]刘贤国,徐红玉,朱江.原发性肝癌伴门静脉癌栓产生机制及经导管肝动脉化疗栓塞术联合其他介入方案治疗研究进展[J].陕西医学杂志,2023,52(10):1438-1441.
[6]鲍宁,陈子超,赵春芹,等.黄芪-莪术药对及其活性成分抗肝癌作用机制研究进展[J].中草药,2023,54(15):5101-5111.
[7]刘炳辉,李鑫,罗志红.补阳还五汤对气虚血瘀型脑出血脑血流参数的影响[J].辽宁中医杂志,2024,51(10):69-72.
[8]沈晓娣,叶盼,边雪梅,等.基于抑木扶土理论的气交灸联合揿针干预经导管肝动脉化疗栓塞术后疼痛、恶心呕吐的临床研究[J].介入放射学杂志,2024,33(9):1014-1018.
[9]中国抗癌协会肝癌专业委员会,中国抗癌协会临床肿瘤学协作专业委员会,中华医学会肝病学会肝癌学组,等.原发性肝癌规范化病理诊断方案专家共识[J].肿瘤,2011,31(4):285-287.
[10]国家食品药品监督管理局.中药新药临床研究指导原则[M].北京:中国医药科技出版社,2002:186-188.
[11]翁瑛,郭守玉,孙惠.加巴喷丁联合文拉法辛治疗糖尿病周围神经病理性疼痛的效果[J].中华神经外科疾病研究杂志,2025,19(3):99-102.
[12]闫红霞,和芳,陈应泰,等.胃癌患者术后3个月内再入院相关因素分析及对营养状态和生活质量的长期影响[J].中华胃肠外科杂志,2023,26(2):191-198.
[13]赵德丽,李玮玮,许映佩,等.基于集束化护理的自我管理干预在肝癌TACE术患者中的效果评价[J].护理实践与研究,2025,22(5):687-692.
[14]蔡之幸,陈越,王阳.调气和营外洗方治疗卒中后肌痉挛疼痛的临床研究[J].辽宁中医杂志,2020,47(4):120-123.
[15]卜献忠,钟远鸣,卜保献,等.脊髓伤方促进脊髓型颈椎病(气虚血瘀证)术后恢复的效果研究[J].时珍国医国药,2023,34(12):2951-2955.
[16]韩晓敏,殷明月,宋杰,等.基于μ阿片受体的双/多靶点镇痛药物研究进展[J].中国药学杂志,2024,59(22):2107-2115.
[17]林木南,许丽梅,薛维婳,等.揿针耳穴联合揉膝推髌点穴法干预训练后诱发膝骨关节炎疼痛的临床研究[J].中华中医药杂志,2024,39(8):4488-4492.
[18]黄婷婷,吴海科,练梦结,等.不同频率重复经颅磁刺激联合补阳还五汤对气虚血瘀型卒中患者运动功能的疗效观察[J].实用医学杂志,2023,39(4):499-504.
[19]许琳,孟丹,刘弘.许润三古方新用治疗慢性盆腔疼痛经验[J].中医杂志,2021,62(9):748-751.
[20]刘杰,梁春玲,陈晓杰,等.四君子汤合防己黄芪汤加减治疗射血分数降低慢性心力衰竭气虚血瘀痰饮证患者的临床疗效[J].重庆医学,2024,53(14):2168-2172.
[21]彭天忠,黄学娣,林星镇,等.开窍醒神针法联合加味补阳还五汤对脑出血恢复期患者(气虚血瘀证)IL-2、MMP-9、BDNF及脑血流量的影响[J].实用医学杂志,2025,41(3):428-433.
[22]江宗霞,周建伟,张开贵,等.桂陈宣化汤联合针刺对气虚血瘀证脑卒中患者的临床疗效[J].中成药,2023,45(4):1137-1141.
[23]殷国江,黎笔熙,魏蓬骁,等.弓状韧带上腰方肌阻滞对机器人辅助前列腺癌根治术老年患者术后镇痛及炎症反应的影响[J].实用医学杂志,2024,40(2):202-206.
[24]刘彦宏,丛树园,武凤,等.补阳还五汤通过调节炎症因子防治血管性痴呆的研究进展[J].中国临床药理学杂志,2024,40(5):749-753.
[25]胡俊翔,包文娟,胡佳,等.揿针联合中药对气滞血瘀型腰椎间盘突出症临床疗效观察[J].中华中医药学刊,2023,41(12):126-129.
[26]葛媛,王贺,周亚滨,等.补阳还五汤加减对急性冠状动脉综合征(气虚血瘀证)患者的中医证候及炎症指标的影响[J].中国中医急症,2021,30(10):1735-1738.

相似文献/References:

[1]王军良.穴位按摩防治腹腔镜胆囊切除术患者苏醒期躁动及其疼痛效果[J].陕西中医,2016,(10):1417.
[2]张升涛,刘宇,陈志伟,等.柏硝祛毒洗剂治疗混合痔术后疼痛临床观察[J].陕西中医,2017,(06):765.
[3]李佩佩,张勇,薛志欣,等.电针对苏丹地区膝骨性关节炎疼痛的疗效观察[J].陕西中医,2017,(06):806.
[4]刘 莉,王丽彬△,刘锐锋,等.壮骨伸筋胶囊治疗腰椎间盘退行性变疗效及对患者SDF1的影响[J].陕西中医,2019,(1):85.
　LIU Li,WANG Libin,LIU Ruifeng,et al.Effect of Zhuanggu Shenjin capsule in the treatment of extensor tendon degeneration of lumbar intervertebral disc and its influence on SDF1[J].,2019,(12):85.
[5]盛平卫,施国荣,曹 伟,等.逍遥越鞠汤加味治疗乳腺增生病临床研究*[J].陕西中医,2019,(7):842.
　SHENG Pingwei,SHI Guorong,CAO Wei,et al.Clinical study on treatment of hyperplasia of mammary glands with Xiaoyao Yueju decoction[J].,2019,(12):842.
[6]许 斌,史栋梁,王子华.痹祺胶囊联合针刺治疗神经根型颈椎病疗效研究*[J].陕西中医,2019,(9):1222.
　XU Bin,SHI Dongliang,WANG Zihua..Clinical analysis of Biqi capsule combined with acupuncture in treating cervical spondylotic radiculopathy[J].,2019,(12):1222.
[7]孙 飞.肩三针温针灸治疗肩周炎疗效及对患者肩关节活动功能的影响[J].陕西中医,2019,(9):1294.
[8]刘 茜,樊亚红△,陈爱林,等.秦息痛药液外敷治疗类风湿关节炎疗效评价*[J].陕西中医,2019,(10):1403.
　LIU Qian,FAN Yahong,CHEN Ailin,et al.Evaluation of the therapeutic effect of external application of Qinxitong liquid onrheumatoid arthritis[J].,2019,(12):1403.
[9]张青天,仝光照,许志会,等.芒针联合脊髓电刺激疗法治疗下肢缺血性疼痛及对患者疼痛与睡眠质量评分的影响[J].陕西中医,2021,(11):1611.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.027]
　ZHANG Qingtian,TONG Guangzhao,XU Zhihui,et al.Effect of Awn needle combined with SCS therapy on PSQI and VAS scores of patients with lower limb ischemic pain[J].,2021,(12):1611.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.027]
[10]高芳芳,李婷婷,崔艺敏,等.针刺作用下嘌呤受体P2X7对神经病理性疼痛的作用[J].陕西中医,2023,(2):271.[doi:DOI:10.3969/j.issn.1000-7369.2023.02.031]
　GAO Fangfang,LI Tingting,CUI Yimin,et al.Effects of purinoceptor P2X7 on neuropathic pain under the action of acupuncture[J].,2023,(12):271.[doi:DOI:10.3969/j.issn.1000-7369.2023.02.031]

备注/Memo

备注/Memo:
江苏省中医药科技发展计划项目(YB2020038)
更新日期/Last Update: 2025-12-08